Pulsatile gonadotrophin releasing hormone stimulation after medium-term pituitary suppression in polycystic ovary syndrome

Hum Reprod. 1993 Nov:8 Suppl 2:197-9. doi: 10.1093/humrep/8.suppl_2.197.

Abstract

Ovulation induction in the polycystic ovary syndrome with pulsatile gonadotrophin releasing hormone (GnRH) in the recovery phase after treatment with a GnRH agonist (GnRHa) during 6-8 weeks has been reported to improve ovulation and pregnancy rates and to normalize follicular phase luteinizing hormone (LH) levels. We studied the results of stimulation with pulsatile GnRH after a shorter 'medium-term' period of 3 weeks of treatment with a GnRHa by comparing a cycle without GnRHa pre-treatment with a cycle with GnRHa (post-GnRHa) pre-treatment in 12 patients. We could prove no significant clinical improvement in post-GnRHa cycles. Ovulation rates were similar. However, in the post-GnRHa cycles, two ongoing pregnancies were observed versus one spontaneous abortion in the cycles without GnRHa pre-treatment. This observation might be explained by the fact that follicular phase LH levels in post-GnRHa cycles were significantly decreased.

MeSH terms

  • Adult
  • Buserelin / administration & dosage
  • Buserelin / therapeutic use
  • Female
  • Follicular Phase / physiology
  • Gonadotropin-Releasing Hormone / administration & dosage*
  • Gonadotropin-Releasing Hormone / therapeutic use
  • Humans
  • Luteinizing Hormone / blood
  • Ovarian Follicle / physiopathology
  • Ovary / diagnostic imaging
  • Ovulation Induction
  • Periodicity
  • Polycystic Ovary Syndrome / diagnostic imaging
  • Polycystic Ovary Syndrome / drug therapy*
  • Polycystic Ovary Syndrome / physiopathology
  • Pregnancy
  • Ultrasonography

Substances

  • Gonadotropin-Releasing Hormone
  • Luteinizing Hormone
  • Buserelin